Cargando…
Insulin glargine in the management of diabetes mellitus: an evidence-based assessment of its clinical efficacy and economic value
INTRODUCTION: Diabetes is a chronic disease associated with high morbidity and mortality, which represents a major public health concern. Interventions that can enhance patient care and reduce clinic visits will not only relieve some of this burden, they will also improve patient QOL and wellbeing....
Autores principales: | Clissold, Rhian, Clissold, Steve |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3012430/ https://www.ncbi.nlm.nih.gov/pubmed/21221178 |
Ejemplares similares
-
Fosphenytoin for the treatment of status epilepticus: an evidence-based assessment of its clinical and economic outcomes
por: Thomson, Andrew
Publicado: (2005) -
Donepezil in Alzheimer’s disease: an evidence-based review of its impact on clinical and economic outcomes
por: Knowles, Joanne
Publicado: (2006) -
Late presentation of toxoplasmosis in renal transplant recipients
por: Clissold, Rhian, et al.
Publicado: (2010) -
Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus
por: Linnebjerg, Helle, et al.
Publicado: (2016) -
Perindopril: the evidence of its therapeutic impact in hypertension
por: Thomson, Andrew, et al.
Publicado: (2007)